Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
3376
AMTD IDEA Group
AMTD
$72.1M
| $14.5K | ﹤0.01% |
13,466
+2,900
| +27% | +$3.09K |
|
3377
SAB Biotherapeutics
SABS
$341M
| $13.6K | ﹤0.01% |
+10,030
| New | +$23K |
|
|
MYND
3378
Mynd.ai
MYND
$18.1M
| $13.5K | ﹤0.01% |
15,844
+400
| +3% | +$498 |
|
3379
Hyperfine
HYPR
$94.7M
| $13.1K | ﹤0.01% |
18,300
-194,000
| -91% | -$199K |
|
|
WLGS
3380
DELISTED
Wang & Lee Group
WLGS
| $12.9K | ﹤0.01% |
47,641
-13,159
| -22% | -$62.7K |
|
3381
CBL International Ltd
BANL
$14.8M
| $12.7K | ﹤0.01% |
+1,000
| New | +$14.4K |
|
3382
TDH Holdings
PETZ
$15.5M
| $12.7K | ﹤0.01% |
11,000
| – | – |
|
3383
TherapeuticsMD
TXMD
$24.1M
| $12.5K | ﹤0.01% |
13,500
+2,609
| +24% | +$2.6K |
|
3384
NextPlat
NXPL
$22M
| $12.1K | ﹤0.01% |
1,460
-1,340
| -48% | -$14K |
|
3385
China Pharma Holdings
CPHI
$44.2M
| $12.1K | ﹤0.01% |
+4,610
| New | +$10.5K |
|
|
LGMK
3386
DELISTED
LogicMark
LGMK
| $12.1K | ﹤0.01% |
+612,107
| New | +$422K |
|
3387
Matinas BioPharma
MTNB
$1.49M
| $11.6K | ﹤0.01% |
22,370
+4,200
| +23% | +$2.49K |
|
|
HYFT
3388
MindWalk Holdings
HYFT
$65.3M
| $11.1K | ﹤0.01% |
29,400
-48,800
| -62% | -$22K |
|
3389
Imunon
IMNN
$6.64M
| $11K | ﹤0.01% |
801
-1,772
| -69% | -$21.2K |
|
3390
TOMI Environmental Solutions
TOMZ
$14.4M
| $10.9K | ﹤0.01% |
+4,431
| New | +$12.5K |
|
3391
Mega Matrix
MPU
$13.7M
| $10.9K | ﹤0.01% |
+16,664
| New | +$15.6K |
|
3392
Acurx Pharmaceuticals
ACXP
$6.36M
| $10.4K | ﹤0.01% |
1,330
+596
| +81% | +$8.03K |
|
|
LGL.WS
3393
DELISTED
LGL Group Inc Warrants
LGL.WS
| $9.22K | ﹤0.01% |
28,823
-8,500
| -23% | -$2.27K |
|
3394
ALX Oncology
ALXO
$268M
| $8.91K | ﹤0.01% |
+14,299
| New | +$17.2K |
|
|
WORX
3395
DELISTED
SCWORX CORP NEW
WORX
| $7.7K | ﹤0.01% |
755
-618
| -45% | -$11.7K |
|
|
FAAS
3396
DELISTED
DigiAsia
FAAS
| $6.15K | ﹤0.01% |
+24,391
| New | +$14.2K |
|
3397
Talphera
TLPH
$62.8M
| $5.99K | ﹤0.01% |
12,100
-7,543
| -38% | -$4.6K |
|
|
HIND
3398
Vyome Holdings
HIND
$15.2M
| $5.88K | ﹤0.01% |
+163
| New | +$39K |
|
3399
IT Tech Packaging
ITP
$2.88M
| $5.82K | ﹤0.01% |
21,233
-11,185
| -35% | -$4.1K |
|
|
RTC
3400
DELISTED
Baijiayun Group
RTC
| $5.39K | ﹤0.01% |
+25,349
| New | +$24K |
|
Similar funds
Jim Simons's Q1 2025 Portfolio in Review
As of Q1 2025, Jim Simons held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Jim Simons added most to Broadcom in Q1 2025, an estimated $513M increase.
- Jim Simons's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Jim Simons fully exited Nike in Q1 2025, selling an estimated $197M.
- Jim Simons's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Jim Simons opened 456 new positions and closed 583 in Q1 2025.
- Jim Simons's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.